The Handbook of Biomarkers
Involved in nearly every therapeutic area, particularly cancer, biomarkers have experienced tremendous advances since the first edition of this book, both in the discovery of biomarkers and in their applications. To aid in this imperative research, Prof. Kewal K. Jain’s Handbook of Biomarkers, Second Edition features a full revision and additional chapters to thoroughly describe many different types of biomarkers and their discovery using various "-omics" technologies, along with the background information needed for the evaluation of biomarkers as well as the essential procedures for their validation and use in clinical trials. With biomarkers described first according to technologies and then according to various diseases, this detailed book features the key correlations between diseases and classifications of biomarkers, which provides the reader with a guide to sort out current and future biomarkers.
Comprehensive and cutting-edge, The Handbook of Biomarkers, Second Edition serves as a vital guide to furthering our understanding of biomarkers, which, by facilitating the combination of therapeutics with diagnostics, promise to play an important role in the development of personalized medicine, one of the most important trends in healthcare today.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Biomarkers of Cancer
Biomarkers of Disorders of the Nervous System
Biomarkers of Cardiovascular Disorders
Biomarkers of Pulmonary Diseases
Biomarkers in Gynecology and Obstetrics
Biomarkers Personalized Medicine
Biomarkers and Regulatory Issues
acid activity acute analysis antibodies antigen apoptosis assay assessment associated atherosclerosis autoantibodies biological biomarker discovery biopsy blood brain breast cancer Cancer Biomarkers cancer patients cardiac cardiovascular disease chronic clinical trials coronary correlated cytokines diabetes diagnostic differential disorders DNA methylation drug development effects elevated enable enzyme epigenetic evaluation expression profiling factor function gene expression genetic genome human identify imaging increased infection inflammation inflammatory injury Jain PharmaBiotech levels lipid lung cancer markers measurement metabolic metabolites metabolomics methods methylation microarray microRNA miRNAs molecular molecules monitoring mRNA multiple sclerosis mutations myocardial novel outcome ovarian cancer oxidative stress pancreatic pathways peptide Pharmacogenomics plasma potential biomarkers predict preeclampsia prognosis prostate cancer protein biomarkers proteomic quantitative receptor renal response risk role samples screening sensitivity serum significantly specific stem cells stroke target therapeutic therapy tion tissue treatment troponin tumor urine validation